Patricia Noguiez‐Hellin

Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical <i>Ex Vivo</i> Gene Therapy Application

Otto-Wilhelm Merten, Sabine Charrier, Nicolas Laroudie et al. · Human Gene Therapy · 2010 · 182 citations

Medicine, Biotechnology, Gene Therapy +13

Gene therapy of RAG-2−/− mice: sustained correction of the immunodeficiency

F Yates, Michèle Malassis-Séris, Daniel Stockholm et al. · Blood · 2002 · 82 citations · Full text

Life Sciences, Genetics, Immunology +12

Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey, Sylvain Thierry, Christophe Russo et al. · Clinical Cancer Research · 2016 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasmoviruses: nonviral/viral vectors for gene therapy.

Patricia Noguiez‐Hellin, Murielle Robert-Le Meur, J L Salzmann et al. · Proceedings of the National Academy of Sciences · 1996 · 29 citations

Life Sciences, Biotechnology, Molecular Biology +17

Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors

Nirmitha I. Herath, Nathalie Berthault, Sylvain Thierry et al. · Frontiers in Oncology · 2019 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17